Apremilast, an Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from a Phase 3, Randomized, Controlled Trial

被引：0

作者：

Edwards, Christopher J. ^{[1
]}

Aelion, Jacob A. ^{[2
]}

Adebajo, Adewale O. ^{[3
]}

Kivitz, Alan ^{[4
]}

Bird, Paul ^{[5
]}

Hu, ChiaChi ^{[6
]}

Stevens, Randall M. ^{[6
]}

Wells, Alvin ^{[7
]}

机构：

[1] Southampton Univ Hosp, Southampton, Hants, England

[2] West Tennessee Res Inst, Jackson, TN USA

[3] Univ Sheffield, Sheffield, S Yorkshire, England

[4] Altoona Arthrit & Osteoporosis Ctr, Duncansville, PA USA

[5] Combined Rheumatol Practice, Kogarah, NSW, Australia

[6] Celgene Corp, Warren, NJ USA

[7] Rheumatol & Immunotherapy Ctr, Franklin, WI USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1572

引用

页码：S694 / S695

页数：2